Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A Phase IIa, Open-Label, Multicenter Study of Single-Agent Tafasitamab (MOR208), an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma: Long-Term Follow-up, Final Analysis

Wojciech Jurczak, MD PhD, Pier Luigi Zinzani, MD PhD, Georg Hess, Gianluca Gaidano, MD PhD, Mariano Provencio, MD, Zsolt Nagy, MD PhD, Tadeusz Robak, MD, Kami J. Maddocks, MD, Christian Buske, MD PhD, Sumeet Ambarkhane, MD MBBS, Wolfram Brugger, Maren Dirnberger-Hertweck, PhD, Sascha Tillmanns, Johannes Weirather, PhD, Kristie Blum

Blood (2019) 134 (Supplement_1): 4078.

https://doi.org/10.1182/blood-2019-124297

Published: 2019

Journal Articles

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Tereza Popkova, MD, Katarina Hradska, MD, Jana Mihalyova, MD, Michaela Skorupova, Tomas Jelinek, MD, Juraj Duras, MD, Zdenek Koristek, MD PhD, Milan Navratil, MD, Katerina Benkova, MD, Hana Plonkova, MD, Jana Zuchnicka, MD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD

Blood (2019) 134 (Supplement_1): 4757.

https://doi.org/10.1182/blood-2019-127011

Published: 2019

Journal Articles

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

Ahmad Zarzour, MD, Ali Tabarroki, MD, Rokana Taftaf, MD, Valeria Visconte, PhD, Jing Ai, MD PhD, Betty K. Hamilton, MD, Nikolaos Papadantonakis, MD PhD, Alan E. Lichtin, Leonard J. Horwitz, MD, Anjali S. Advani, MD, Mikkael A. Sekeres, MD MS, Ramon V. Tiu, MD

Blood (2014) 124 (21): 1835.

https://doi.org/10.1182/blood.V124.21.1835.1835

Published: 2014

Journal Articles

Post-Transplant Cyclophosphamide and Bortezomib Combination for Prevention of GvHD after Allogeneic Blood and Marrow Transplantation Is Feasible and Produces Favorable Outcomes

A. Samer Al-Homsi, MD, Tara S Roy, NP, Kelli Cole, RN, MSN, Marlee Bogema, RN, BSN, Stephanie F Williams, MD, Ulrich A. Duffner, MD, Aly Mageed, MD

Blood (2014) 124 (21): 3920.

https://doi.org/10.1182/blood.V124.21.3920.3920

Published: 2014

Journal Articles

The Attitude of Canadian University Students towards a Behaviour-Based Blood Donor Health Assessment Questionnaire

Stephanie Lynn Go, BSc, Cindy Tze-Yung Lam, BSc, Yahui Tammy Lin, BSc, Deborah Joanne Wong, BMSc, Alejandro Lazo-Langner, MD, MSc, Ian H. Chin-Yee, MD, FRCPC

Blood (2010) 116 (21): 3342.

https://doi.org/10.1182/blood.V116.21.3342.3342

Published: 2010

Journal Articles

Low Incidence of Opportunistic Infections in CLL Patients Treated with Single Agent Flavopiridol.

Leslie A. Andritsos, MD, Beth Fischer, R.N., Thomas S. Lin, M.D., Kristie A. Blum, M.D., Jeffrey A. Jones, M.D., Mollie E. Moran, C.N.P., John C. Byrd, M.D., Michael R. Grever, M.D.

Blood (2007) 110 (11): 3128.

https://doi.org/10.1182/blood.V110.11.3128.3128

Published: 2007

Journal Articles

Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.

Brady Beltran-Garate, MD, Henry Gomez, MD, Jose L. Lopez, MD, Mildred Borrego, MD, Mercedes Prieto, MD, Antonio A. Carrasco-Yalan, MD, Julia Huamani, PharmD, Jorge Castillo, MD, Osiris da Costa, MD

Blood (2007) 110 (11): 3425.

https://doi.org/10.1182/blood.V110.11.3425.3425

Published: 2007

Journal Articles

Polyclonal Hypergammaglobulinemia in a Randomized Sample of Ghanaian Adult Males.

Francis Buadi, MB, ChB, Jerry A. Katzmann, Ph.D, Ruth M. Pfeiffer, Ph.D, Ann W. Hsing, Ph.D, Edward D. Yeboah, MD, Richard B. Biritwum, MD, Angela Dispenzieri, MD, Robert Kyle, MD, Vincent Rajkumar, MD, Ola Landgren, MD., PhD

Blood (2007) 110 (11): 960.

https://doi.org/10.1182/blood.V110.11.960.960

Published: 2007

Journal Articles

Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.

Dong Hwan Kim, MD, PhD, Hans Messner, MD, PhD, Vikas Gupta, MD, MRCP, John Kuruvilla, MD, Janice Wright, MS, ACNP(C), Jeffrey Lipton, MD, PhD

Blood (2006) 108 (11): 3373.

https://doi.org/10.1182/blood.V108.11.3373.3373

Published: 2006

NARROW

A Phase IIa, Open-Label, Multicenter Study of Single-Agent Tafasitamab (MOR208), an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma: Long-Term Follow-up, Final Analysis

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Rates of Infection in Myelofibrosis Patients Treated with Ruxolitinib

Post-Transplant Cyclophosphamide and Bortezomib Combination for Prevention of GvHD after Allogeneic Blood and Marrow Transplantation Is Feasible and Produces Favorable Outcomes

The Attitude of Canadian University Students towards a Behaviour-Based Blood Donor Health Assessment Questionnaire

Low Incidence of Opportunistic Infections in CLL Patients Treated with Single Agent Flavopiridol.

Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.

Polyclonal Hypergammaglobulinemia in a Randomized Sample of Ghanaian Adult Males.

Factors Influencing Varicella-Zoster Virus (VZV) Infection after Allogeneic Peripheral Blood Stem Cell Transplantation: Low-Dose Acyclovir Prophylaxis and Pre-Transplant Diagnosis of Lymphoproliferative Disorders.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only